IL1B and rheumatoid arthritis: inhibited the PI3K/AKT/NF-κB pathways closely related to RA by suppressing the expression of inflammatory cytokines IL-1β, COX-2, and iNOS in vitro when used in a concentration between 1 and 30 μg/mL [310].